# Phase 31.4.4A execution-contract correction authorization V1

Status: authorized for future support-producer implementation only. This
document authorizes no database, lifecycle, deployment, or external-system
operation.

Phase 31.4.4 and its V2 contract remain immutable historical evidence. The
Phase 31.4.5 feasibility gate found, before any execution, that V2 classified
required Freeze 0 fields but did not bind their executable values. No database,
role, migration, support fixture, or lifecycle state was created.

`PHASE31_4_4A_ROW_LEVEL_EXECUTION_CONTRACT_V2_1.json` supersedes V2 only for
future operational field bindings. It retains the same 118 qualified member
identities, producers, security/RLS matrix, freeze order, semantic registry,
closure, and architecture. ADR-0018 remains governing; no ADR-0019 is required.
The original support-producer architecture and its parameterless business
interface remain unchanged, and a future producer must consume V2.1 directly.

Phase 29 identifiers are historical references only and are prohibited as
operational inputs. RuntimeAdoption and its resolver remain prohibited.
AdminApps is not contacted: the tenant and actor boundary uses visibly
synthetic test-only references plus fresh fail-closed authority provenance at
the exact future evaluation point. MedSupplier and external APIs are outside
scope.

This authorization closes only
`P1-FREEZE0-ROW-MATERIAL-BINDINGS`. It does not close
`P1-CR2-SUPPORT-PRODUCER-ABSENT` or
`P1-CR2-INPUT-HASH-INVENTORY`; those remain implementation work for Phase
31.4.5 Retry 2. Diagnostics and this addendum are not operational authority.
